Piper Jaffray Starts Transcept Pharmaceuticals (TSPT) at Overweight
Tweet
Share
E-mailGet Alerts TSPT Hot Sheet
Price: $1.70 --0%
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 6
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 6
Join SI Premium – FREE
Piper Jaffray initiates coverage on Transcept Pharmaceuticals (NASDAQ: TSPT) with a Overweight. PT $8.00.
For an analyst ratings summary and ratings history on Transcept Pharmaceuticals click here. For more ratings news on Transcept Pharmaceuticals click here.
Shares of Transcept Pharmaceuticals closed at $4.74 yesterday.
For an analyst ratings summary and ratings history on Transcept Pharmaceuticals click here. For more ratings news on Transcept Pharmaceuticals click here.
Shares of Transcept Pharmaceuticals closed at $4.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler Starts Jasper Therapeutics (JSPR) at Overweight
- Berenberg Resumes IP Group Plc (IPO:LN) (IPZYF) at Buy
- Chardan Starts QumulusAI (QMLS) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
